- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about QDEL
Recent news which mentions QDEL
12 Health Care Stocks Moving In Thursday's Intraday Session
December 23, 2021
From Benzinga
OCDX Stock Alert: 9 Things to Know About the Quidel Deal Sending Ortho Clinical Higher
December 23, 2021
From InvestorPlace
Mid-Day Market Update: Nasdaq Rises 100 Points; Quidel Shares Plummet
December 23, 2021
From Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
December 23, 2021
From Benzinga
Tesla Leads Automobile Stocks to be Among Wednesday's Top Performers
December 23, 2021
From Benzinga
From Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 23, 2021
From Benzinga
Quidel To Buy Ortho Clinical Diagnostics For $24.68/Share: Highlights
December 23, 2021
From Benzinga
COVID Testing Kit Makers Respond To Biden's Call For 500 Million Free At-Home Tests
December 21, 2021
From Benzinga
Where’s corporate America?At-home COVID tests are a free-market flop
December 21, 2021
From MarketWatch
QDEL Stock Alert: What Is Going on With Quidel Today?
December 20, 2021
From InvestorPlace
7 Stocks to Buy to Hedge Against Omicron Variant Risks
December 13, 2021
From InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
December 06, 2021
From Benzinga
Biden’s plan for free and easy at-home COVID-19 tests may not be as simple as it sounds. ‘Like everything we do in health care in America, we make it complicated’
December 03, 2021
From MarketWatch
From Benzinga
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
Quidel Clocks Interim Q3 Sales Twice Of Wall Street Expected
October 08, 2021
Tickers
QDEL
From Benzinga
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
5 Stocks To Watch For October 8, 2021
October 08, 2021
From Benzinga
These 2 COVID-19 Stocks Could Boost the Market Friday
October 07, 2021
From Motley Fool
12 Health Care Stocks Moving In Thursday's After-Market Session
October 07, 2021
From Benzinga
From Benzinga
2 Growth Stocks to Buy if You're Worried COVID Is Here to Stay
October 02, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.